Journal of Clinical Medicine · Nov 16, 2026

Hormonal Therapy for Osteoporosis: Mechanisms, Trial Evidence, and Current Place in Fracture Prevention

By Tenev D, Cherkezov N, Enev G et al.

Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and fracture risk. Estrogen deficiency is its principal cause in postmenopausal women, sex steroid deficiency is a common cause in men, and several fracture-preventing drugs act on hormonal pathways, although the most widely prescribed agents, the bisphosphonates and denosumab, do not. This narrative review summarizes the randomized trial evidence for estrogen, selective estrogen receptor modulators, the tissue-selective estrogen complex, tibolone, progestogens, parathyroid hormone receptor agonists, and androgens, and for the iatrogenic hypogonadal states produced by androgen deprivation therapy, aromatase inhibitors, gonadotropin-releasing hormone agonists, and glucocorticoids. PubMed, Embase, and the Cochrane Library were searched to September 2026, with priority given to randomized trials with fracture endpoints. Estrogen reduces vertebral and hip fracture in women recruited without regard to bone mineral density, and the benefit ends when treatment ends. Parathyroid hormone receptor agonists produce the largest early reduction in vertebral fracture of any hormonal agent, and the gain is lost unless an antiresorptive drug follows. Testosterone raises bone mineral density in older men but did not reduce fracture in the one adequately powered randomized trial, in which fracture incidence was higher on treatment than on placebo. Hormonal agents are therefore selected for their extraskeletal profile or to correct a hormonal deficit, alongside rather than in place of bisphosphonates, denosumab, and romosozumab. Implications for fracture liaison, perioperative planning, and implant fixation are discussed, and the open questions are stated as specific comparisons.

doi.org/10.3390/jcm15228962Interventions

AgingResearch.News